Compare LEGO & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEGO | ANL |
|---|---|---|
| Founded | 2025 | 2004 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.2M | 293.4M |
| IPO Year | 2026 | 2022 |
| Metric | LEGO | ANL |
|---|---|---|
| Price | $9.87 | $6.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 5.3K | ★ 181.7K |
| Earning Date | N/A | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.87 | $0.88 |
| 52 Week High | $9.90 | $12.09 |
| Indicator | LEGO | ANL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 36.85 |
| Support Level | N/A | $1.36 |
| Resistance Level | N/A | $9.98 |
| Average True Range (ATR) | 0.00 | 0.76 |
| MACD | 0.00 | -0.24 |
| Stochastic Oscillator | 0.00 | 5.56 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.